As Pharma Withdraws from R&D a Golden Age for BD Begins!
Stewart Adkins, Stewart Adkins Advisors
Ed Saltzman Presentation Notes (contains link to presentation)
Local Partnering Deals,
Hans-Joachim Egly, UCB
Growth Strategies for National Companies,
John Dawson, Alliance Pharma
How a Canadian Company Internationalises,
Mark Nawacki, Paladin Labs
Canada, at the Frontier of Biopharma R&D,
Isabelle Trempe, CHLA
Market Access in Europe,
Andrew Green, Pfizer
The Paediatric Investigation Plan,
Ulrich Granzer, Granzer Regulatory Consulting & Services
Pricing Negotations,
T Fitzgerald & J Furniss, Bridgehead.
Regulatory Data Protection in Global Marketing Authorisation,
Burkhard Straeter, Attorney at Law
Cost Containment Within Healthcare Markets,
Sarah Rickwood, IMS Health
Mid Cap Company Strategies,
Jaume Masana, Esteve
Alternative Sources of Finance,
Ken Powell, Q Chip
Biotech Partnering in Difficult Times,
Klaus Maleck, Evotec
A Venture Capital View of BD,
Karen Wagner, Ysios Capital Partners
How Payers Decide Asset Values in Europe,
Adam Hutchings, GMAS
Maximising Sales in Europe - Accessing the Not 5 Top Markets
Markus Werner, Nycomed
Downloads
Some presentations are not available for reasons of confidentiality